Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2012		Sep. 30, 2011
Cash flows from operating activities:
Net income	$ 364,775		$ 24,300
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	10,000		26,000
Net gain on sales of loans	(71,482)		(33,754)
Net gain on sales of investments and MBS	(12,592)		(14,298)
Net gain on mortgage servicing rights	984		(4,253)
Other than temporary impairment	6,819	[1]	0	[1]
Stock based compensation	2,756		2,949
(Gain) loss on OREO	32		17,380
Release of DTA valuation allowance	(288,842)		0
Increase in cash surrender value of BOLI	(6,924)		(4,804)
Depreciation and amortization	33,871		30,161
Change in:
Accrued interest receivable	4,325		469
Prepaid expenses and other assets	(23,295)		4,246
Accrued interest payable	(16,116)		3,893
Accrued expenses and other liabilities	19,606		(1,279)
Proceeds from sales of loans originated for sale	1,937,131		1,394,273
Loans originated for sale	(2,010,310)		(1,399,822)
Net cash provided by operating activities	(49,262)		45,461
Cash flows from investing activities:
Change in restricted cash	(11,042)		(3,514)
Net change in loans	(317,773)		(254,078)
Proceeds from sales of loans	75,689		39,320
Purchase of investment securities	(3,734)		(9,857)
Proceeds from maturities of investment securities	18,939		478
Proceeds from sale of investment securities	179,235		30,987
Purchase of MBS	(287,849)		(264,156)
Principal payments received on MBS	467,792		341,827
Proceeds from sales of MBS	326,915		353,444
Proceeds from Life Insurance Policies	3,714		0
Office properties and equipment, net	(14,144)		(13,069)
Improvements and other changes to OREO	(1,214)		(5,357)
Proceeds from sales of OREO	67,200		197,528
Net change in cash and cash equivalents from acquisitions	121,098		0
Net cash provided by investing activities	624,826		413,553
Cash flows from financing activities:
Net change in deposits	(441,827)		(431,767)
Proceeds from Federal Home Loan Bank Borrowings	50,000		0
Repayment of advances from FHLB	(300,157)		(148)
Net change in securities sold under repurchase agreements and funds purchased	(113,216)		23,840
Proceeds from stock issuance, net	572		0
Dividends, Common Stock, Cash	(9,322)		0
Net cash used in financing activities	(813,950)		(408,075)
Net change in cash and cash equivalents	(238,386)		50,939
Cash and cash equivalents, beginning of period	470,599		411,583
Cash and cash equivalents, end of period	232,213		462,522
Supplemental disclosures:
Interest	82,358		79,684
Income taxes, net	81		0
Noncash financing and investing activities:
Foreclosed real estate acquired in settlement of loans	$ 30,683		$ 159,464

[1] The other-than-temporary impairment recognized in earnings during the second quarter of 2012 did not have a portion recognized in accumulated other comprehensive income. See Note 3.